Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
145 USD | -0.03% | -7.05% | -7.87% |
Sales 2024 * | 88.37B 7,357B | Sales 2025 * | 90.82B 7,562B | Capitalization | 348B 28,943B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 1,835B | Net income 2025 * | 23.09B 1,923B | EV / Sales 2024 * | 3.85 x |
Net cash position 2024 * | 7B 583B | Net cash position 2025 * | 19.84B 1,652B | EV / Sales 2025 * | 3.61 x |
P/E ratio 2024 * |
16
x | P/E ratio 2025 * |
15.2
x | Employees | 1,31,900 |
Yield 2024 * |
3.34% | Yield 2025 * |
3.49% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
1 day | -0.03% | ||
1 week | -7.05% | ||
Current month | -0.68% | ||
1 month | -3.38% | ||
3 months | -9.80% | ||
6 months | -4.91% | ||
Current year | -7.87% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 145 | -1.02% | 34 |
28/24/28 | 146.5 | -1.64% | 41 |
24/24/24 | 149 | -4.52% | 17 |
22/24/22 | 156 | +1.63% | 6 |
21/24/21 | 153.5 | +0.26% | 32 |
End-of-day quote Kazakhstan S.E., May 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.17% | 731B | |
+31.34% | 586B | |
+16.39% | 319B | |
+0.31% | 273B | |
+13.45% | 235B | |
-6.75% | 203B | |
+7.45% | 202B | |
+3.17% | 159B | |
-3.09% | 158B |
- Stock Market
- Equities
- JNJ Stock
- JNJ_KZ Stock